Anti-aging pill targets brittle bones in new trial
NCT ID NCT06018467
First seen Feb 01, 2026 · Last updated May 24, 2026 · Updated 12 times
Summary
This study tests whether drugs that remove aged 'senescent' cells from the body can improve bone health in older adults with weak bones (osteopenia or osteoporosis). About 120 men and women aged 60-90 with increased fracture risk will receive senolytics or a placebo. The main goal is to see if these drugs safely reduce bone breakdown and improve bone formation markers over 21 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOPENIA, OSTEOPOROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Odense University Hospital
Odense, 5000, Denmark
Conditions
Explore the condition pages connected to this study.